Truist Raises Its Price Target on Unum (UNM) to $96

Why It Matters

The upgraded targets signal confidence in Unum’s earnings momentum and suggest the stock may be undervalued relative to its peers, influencing portfolio allocations in the insurance sector.

Key Takeaways

• Truist lifts Unum price target to $96, up from $88
• Keefe Bruyette raises its target to $105, maintaining Outperform
• Q1 EPS beat at $2.14 versus $2.05 consensus
• Revenue topped $3.36 B, exceeding $3.0 B estimate
• Company repurchased $400 M shares and paid $78 M dividends

Pulse Analysis

Unum Group’s recent analyst upgrades underscore a broader shift in the U.S. benefits‑insurance landscape. Truist’s move to a $96 price target reflects confidence that the company’s core life‑insurance franchise is delivering consistent premium growth, while Keefe Bruyette’s higher $105 target suggests the market may be underpricing Unum’s earnings power. Both firms cite the Q1 beat and a robust Group Life segment as catalysts, positioning Unum as a potential outperformer in a sector where many peers face pricing pressure.

The insurer’s Q1 results revealed a $2.14 earnings per share, topping the $2.05 consensus, and revenue of $3.36 billion, well above the $3.0 billion forecast. Strong persistency rates and a healthier closed‑block risk profile indicate that policyholders are staying longer, reducing lapse risk and enhancing cash‑flow stability. Management’s $400 million share‑repurchase program and $78 million dividend payout signal confidence in balance‑sheet strength and a commitment to returning capital to shareholders, further supporting the bullish analyst outlook.

Looking ahead, Unum projects FY26 EPS of $8.60‑$8.90, roughly in line with consensus, suggesting modest upside but limited downside. Compared with peers such as MetLife and Prudential, Unum trades at a discount on price‑to‑earnings multiples, offering a value proposition for investors seeking exposure to employee benefits and life‑insurance products. However, the company must navigate regulatory scrutiny and potential macro‑economic headwinds that could affect premium growth. Overall, the upgraded targets and solid quarterly performance make Unum a compelling watch for insurers and dividend‑focused portfolios.